| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 266-267 |
| Número de páginas | 2 |
| Publicación | International Journal of Cardiology |
| Volumen | 250 |
| DOI | |
| Estado | Published - ene 1 2018 |
Financiación
Dr. Pepine receives support from the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine; NIH/NHLBI--UFRCC for the Cardiovascular Cell Therapy Research Network and Training Core Supplement HL087366, Brain-Gut Microbiome-Immune Axis in Hypertension HL132448, and Angiotensin and Neuroimmune Activation in Hypertension HL033610; US Dept. of Defense CDRMP Ischemia-Intensive Medical Treatment Reduces Events in Women with Nonobstructive CAD PR161603; NIH NCATS—University of Florida Clinical and Translational Science UL1TR001427; and PCORnet-OneFlorida Clinical Research Consortium CDRN-1501-26,692.
| Financiadores | Número del financiador |
|---|---|
| Avedisian School of Medicine Department of Medicine | |
| Gatorade Trust | |
| NIH NCATS | |
| UFRCC | HL087366, HL132448 |
| Clinical and Translational Science Institute, University of Florida | UL1TR001427 |
| National Institutes of Health (NIH) | |
| U.S. Department of Defense | |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| Florida AandM University and Florida State University |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Huella
Profundice en los temas de investigación de 'High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver